title: Bupropion for the treatment of neuropathic pain.
abstract: Neuropathic pain is a common problem in clinical practice, affecting patients physically, emotionally, financially, and socially. Current treatment includes antidepressants, antiepileptics, and opioid analgesics. Bupropion is a specific inhibitor of neuronal noradrenaline reuptake and a weak inhibitor of dopamine reuptake, which shows some promise in the treatment of neuropathic pain.
authors.affiliation: East Tennessee State University, Quillen College of Medicine, Johnson City, TN, USA. drtanmayshah@gmail.com
authors.forename: Tanmay H
authors.initials: TH
authors.lastname: Shah
authors.forename: Abdolali
authors.initials: A
authors.lastname: Moradimehr
mesh_terms: D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D016642:Bupropion / Q000627:therapeutic use*; D002908:Chronic Disease; D018849:Controlled Clinical Trials as Topic; D018765:Dopamine Uptake Inhibitors / Q000627:therapeutic use*; D006801:Humans; D009437:Neuralgia / Q000188:drug therapy*; D014179:Neurotransmitter Uptake Inhibitors / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy; D010166:Palliative Care / Q000379:methods; D016896:Treatment Outcome
chemical_list: D018712:Analgesics, Non-Narcotic; D018765:Dopamine Uptake Inhibitors; D014179:Neurotransmitter Uptake Inhibitors; D016642:Bupropion